Publications by authors named "Jaroslav Bacovsky"

Claim this Profile
I
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.
Jiri Minarik, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Jaroslav Bacovsky

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone metabolism parameters and their relation to cytogenetics in multiple myeloma.
Petra Krhovska, Tomas Pika, Jitka Proskova, Jana Balcarkova, Jana Zapletalova, Jaroslav Bacovsky

Eur J Haematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment.
Katarina Chroma, Zdenek Skrott, Jan Gursky, Jaroslav Bacovsky, Pavel Moudry

Cell Death Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma.
Jiri Minarik, Tomas Szotkowski, Jan Hrbek, Petra Krhovska, Eva Buriankova, Jaroslav Bacovsky

Clin Case Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice.
Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Jaroslav Bacovsky

BMC Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapy.
Jiri Minarik, Martin Novak, Patrik Flodr, Jana Balcarkova, Miroslava Mlynarcikova, Jaroslav Bacovsky

Eur J Haematol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of signalling pathways in myeloma bone disease with regard to activity of the disease, extent of skeletal involvement and correlation to bone turnover markers.
Jiri Minarik, Zuzana Hermanova, Pavla Petrova, Jan Hrbek, Jana Zapletalova, Jaroslav Bacovsky

Eur J Haematol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies.
Jiri Minarik, Petra Krhovska, Jan Hrbek, Tomas Pika, Jaroslav Bacovsky

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse.
Miroslava Mlynarcikova, Jana Balcarkova, Pavla Mickova, Vlastimil Scudla, Tomas Pika, Jaroslav Bacovsky

Clin Lymphoma Myeloma Leuk· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy.
Jiri Minarik, Petr Pavlicek, Ludek Pour, Tomas Pika, Vladimir Maisnar, Jaroslav Bacovsky

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Vlastimil Scudla, Pavel Lochman, Tomas Pika, Jiri Minarik, Jana Zapletalova, Jaroslav Bacovsky

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Vlastimil Ščudla, Pavel Lochman, Tomáš Pika, Jana Zapletalová, Jiří Minařík

Cas Lek Cesk· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Vlastimil Ščudla, Pavla Petrová, Tomáš Pika, Pavel Lochman, Jiří Minařík

Cas Lek Cesk· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT.
Jaroslav Bacovsky, Miroslav Myslivecek, Jiri Minarik, Vlastimil Scudla, Tomas Pika

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bortezomib-based therapy in patients with light chain deposition disease].
Jiří Minařík, Tomáš Tichý, Tomáš Pika, Jaroslav Bačovský, Dagmar Adamová

Vnitr Lek· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10 years of experience with thalidomide in multiple myeloma patients: report of the Czech Myeloma Group.
Jiri Minarik, Viera Sandecka, Vladimir Maisnar, Evzen Gregora, Ivan Spicka, Jaroslav Bacovsky

Leuk Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of hepatocyte growth factor, syndecan-1, and osteopontin in multiple myeloma and monoclonal gammopathy of undetermined significance.
Jiri Minarik, Tomas Pika, Jaroslav Bacovsky, Pavla Petrova, Katerina Langova

ScientificWorldJournal· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients.
Jiri Minarik, Tomas Pika, Jaroslav Bacovsky, Katerina Langova, Vlastimil Scudla

Br J Haematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of imaging methods in POEMS syndrome.
Jiri Minarik, Vlastimil Scudla, Jaroslav Bacovsky, Tomas Pika, Filip Ctvrtlik

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement.
Jiri Minarik, Vlastimil Scudla, Tomas Tichy, Tomas Pika, Jaroslav Bacovsky

Leuk Lymphoma· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined measurement of plasma cell proliferative and apoptotic index in multiple myeloma defines patients with good and poor prognosis.
Jiri Minarik, Vlastimil Scudla, Marta Ordeltova, Tomas Pika, Jaroslav Bacovsky

Leuk Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
Jaroslav Bacovsky, Miroslav Myslivecek, Vlastimil Scudla, Pavel Koranda, Eva Buriankova

Clin Nucl Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of plasma cell proliferative and apoptotic indices in the course of multiple myeloma.
Jiri Minarik, Vlastimil Scudla, Marta Ordeltova, Jaroslav Bacovsky, Tomas Pika

Leuk Lymphoma· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual manifestation of multiple myeloma: focal affection of central nervous system in a patient with chronic lymphocytic leukaemia.
Tomas Pika, Jaroslav Bacovsky, Miroslav Vaverka, Jan Hrbek, Jaromir Hubacek

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between some soluble osteogenic markers, angiogenic cytokines/other biological parameters and the stages of multiple myeloma evaluated according to the Durie-Salmon and International Prognostic Index stratification systems.
Vlastimil Scudla, Tomas Pika, Marie Budikova, Pavla Petrova, Jaroslav Bacovsky

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis